BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Hua Medicine May be Sending Type 2 Diabetes into Remission

  The analysis showed a 52-week glucose remission rate of 65.2% among the 69 patients being followed.

  September 27, 2021

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Psychiatry on the Brink: Precision Medicine Finally Streamlines Therapeutic Selection

  Eriksson said that HMNC Brain Health is a pioneer in developing precision medicine for the psychiatric space.

  September 27, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Policy

  Implications of the Elizabeth Holmes Trial on High-Risk Fundraising in Silicon Valley

  Industry watchers question why Elizabeth Holmes has been singled out for failing to deliver what she promised while other tech executives are given a pass.

  September 27, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  Oral COVID-19 Vaccine Candidate Seeks to Protect People Living With Positive Patients

  The initiative marks a milestone in the biopharmaceutical industry’s COVID-19 response efforts as it now seeks to protect not just those who had contracted the virus but also those who are around them.

  September 27, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Drug Development

  Biohaven’s Verdiperstat Falls Flat in Multiple System Atrophy

  Biohaven Pharma’s latest update on its Phase III clinical trial to use verdiperstat as a potential treatment for multiple system atrophy showed that it did not meet its expected outcomes.

  September 27, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Policy

  Big Pharma Players Settle Court Battles with Cash

  Diabetes player Novo Nordisk cut a deal this week, announcing a settlement agreement to put an end to a lawsuit filed in January 2017 by American Depository Receipt investors.

  September 27, 2021

   · 

  3 min read

   · 

  Kate Goodwin
• 

  Business

  Life Sciences Industry Sees Flurry of Expansions in September

  Here’s a look at a few of the industry expansions that have been announced so far this month.

  September 27, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  Intra-Cellular Bipolar Drug Shows “Significant” Benefit in Depressive Episodes

  Intra-Cellular Therapies published its Study 404 Phase III trial of lumateperone as monotherapy for major depressive episodes associated with bipolar I or bipolar II disorder.

  September 27, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  Ziopharm Eliminates 60 Positions in Strategic Workforce Reduction

  Less than a month after appointing a new chief executive officer, Ziopharm Oncology announced a restructure that has resulted in over 50% of its workforce being axed.

  September 27, 2021

   · 

  2 min read

   · 

  Ellen Bombela
• 

  Drug Development

  COVID Update: COVID-19 Cuts Life Expectancy to WWII Levels, Regeneron and Boosters

  With Pfizer expected to submit its COVID-19 vaccine data for children five to 11 years to regulators, a study showed just how damaging the pandemic has been to life expectancy. Here’s a look.

  September 27, 2021

   · 

  4 min read

   · 

  Mark Terry